Inoviem Scientific raises €750k ($800k) from existing financial partners
Aelix Therapeutics appoints Dr. Ian McGowan as Chief Medical Officer
Nosopharm raises €2.4 million ($2.6M) to develop a novel antibiotic class
Minoryx Therapeutics successfully completes phase 1 clinical trial for lead candidate MIN-102
PeptiMimesis receives second tranche of seed funding
Minoryx Therapeutics receives Orphan Drug Designation from the US FDA
Dr Claude Nicaise joins Minoryx Therapeutics as independent board member
Prexton Therapeutics Series B financing round raises €29 million ($31M) to advance its novel Parkinson’s therapeutic
